Covilife 20 mg Ivermectin Tablets contain ivermectin USP 20 mg and are used for certain susceptible parasitic infections. Covilife 20 mg should be used exactly as prescribed by a qualified healthcare professional. The appropriate dose depends on the diagnosed condition, body weight and clinical circumstances.

Covilife 20 mg is an oral antiparasitic tablet containing ivermectin USP 20 mg. The current Kachhela Medex product information identifies Covilife-20 as an uncoated ivermectin tablet and lists strongyloidiasis and onchocerciasis among its uses. It also describes physician-directed use for conditions such as scabies and selected other parasitic infections.

Ivermectin treatment is condition- and weight-dependent, so the 20 mg tablet should not be treated as a standard dose for every person. U.S. prescribing information for ivermectin uses weight-based dosing for approved indications. Review the product details and proceed only after confirming the appropriate medical and destination requirements.

Covilife 20 mg Ivermectin Tablets

Name: Covilife 20 mg Ivermectin Tablets
Brand: Ivermectinkart
Price: 190 USD
Availability: InStock

$190.00

Pack Size

Quantity

Covilife 20 mg contains ivermectin, an anthelmintic medicine used against certain susceptible parasites. Established oral ivermectin uses include:

Strongyloidiasis: infection of the intestinal tract caused by Strongyloides stercoralis. DailyMed

Onchocerciasis: infection caused by Onchocerca volvulus, commonly known as river blindness. Ivermectin acts on developing worms rather than adult worms. MedlinePlus

Scabies: oral ivermectin may be used in selected circumstances under medical direction; approval and treatment recommendations vary by country.

Certain other parasitic infections: use should be based on a clinician's diagnosis and advice rather than the product's broad antiparasitic classification. MedlinePlus

The manufacturer's list includes scabies, head lice and other susceptible parasitic infections, but these uses should not be interpreted as universal approvals in every country.
Ivermectin interferes with nerve and muscle signalling in susceptible parasites. It binds to parasite glutamate-gated chloride channels, increasing chloride movement and disrupting normal neuromuscular activity. The affected parasite becomes immobilized and is subsequently eliminated.

The effect differs according to the infection. For strongyloidiasis, ivermectin kills the worms in the intestine. For onchocerciasis, it kills developing forms of the parasite but does not kill the adult worms, which is why medical follow-up may be needed.

Covilife 20 mg should be taken exactly as prescribed. Do not decide how many 20 mg tablets to take by comparing the tablet strength with another ivermectin product.

Point	General guidance
Route	Oral
Dosage form	Uncoated tablet
Strength	Ivermectin USP 20 mg
Administration	U.S. ivermectin labeling directs patients to take tablets on an empty stomach with water
Dose selection	Depends on the infection, body weight and clinical circumstances
Repeat treatment	Depends on the diagnosed infection and medical follow-up

For U.S.-approved oral indications, ivermectin labeling uses approximately 200 micrograms/kg for strongyloidiasis and 150 micrograms/kg for onchocerciasis. These are general label parameters, not an individualized dosing calculation for Covilife 20 mg.

Commonly reported effects of oral ivermectin include dizziness, nausea, vomiting, abdominal discomfort, diarrhea, constipation, weakness and reduced appetite. Reactions associated with treatment of onchocerciasis can also include swelling, joint symptoms, fever and eye-related symptoms. MedlinePlus

Important interaction and monitoring points include:

Tell the doctor or pharmacist about all prescription medicines, nonprescription medicines, vitamins and supplements.

Warfarin and ivermectin may require particular attention; the healthcare professional should decide whether monitoring or other precautions are appropriate.

People being treated for strongyloidiasis who have Loa loa infection or have lived in or travelled through areas where loiasis is common may be at risk of serious neurological reactions. MedlinePlus

Severe rash, blistering or peeling skin, confusion, loss of consciousness or other major neurological symptoms require urgent medical attention.
The supplied Covilife product literature describes storage in a cool, dry and dark place and keeping the medicine out of children's reach. Imimg For general ivermectin tablets, MedlinePlus advises keeping the medicine tightly closed at room temperature and away from excess heat and moisture. MedlinePlus

Current Kachhela Medex product pages verify these additional Covilife ivermectin strengths:

12 mg

20 mg

24 mg

40 mg Kachhela Medex

These strengths are not automatically interchangeable. The appropriate strength depends on the prescribed regimen and the specific product.
Do not use Covilife 20 mg if you have a known allergy to ivermectin or an ingredient in the tablet. Tell your healthcare professional about pregnancy, breastfeeding, immune-system conditions and all medicines or supplements you take. U.S. ivermectin labeling states that safety and effectiveness have not been established in children weighing less than 15 kg. DailyMed

Pregnancy requires specific medical advice because adequate controlled studies in pregnant women have not established safety. Breastfeeding also requires an individual risk assessment. DailyMed

Extra caution is needed where Loa loa infection is possible because severe neurological reactions can occur after ivermectin treatment. Seek urgent care for seizures, severe confusion, loss of consciousness, difficulty walking or standing, severe allergic symptoms, blistering or peeling skin, or significant breathing problems.

Do not use animal ivermectin products in humans. FDA-approved human ivermectin products and veterinary formulations are not interchangeable. FDA also states that ivermectin tablets are approved for certain parasitic infections, not for preventing or treating COVID-19. U.S. Food and Drug Administration

This information is for general education and does not replace advice from a doctor, pharmacist or qualified healthcare professional.